Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Aggressive angiomyxoma--a new clinico-pathologic entity]

J Vajó1, A Böör, L Sokol

  • 1II. chirurgická klinika FN L. Pasteura, LF UPJS, Kosice.

Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trial.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Tagraxofusp, a novel CD123-directed cytotoxin to treat blastic plasmacytoid dendritic cell neoplasm.

Drugs of today (Barcelona, Spain : 1998)·2020
Same author

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes.

Blood cancer journal·2015
Same author

Utility of ¹⁸fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

[Intestinal endometriosis - a case report].

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2014
Same author

Primary obstructed megaureter (POM) in children.

Bratislavske lekarske listy·2013

Aggressive angiomyxoma is a rare tumor. Complete surgical removal is key, but local relapses are common, even without clinical symptoms.

Area of Science:

  • Oncology
  • Pathology

Background:

  • Aggressive angiomyxoma is a rare clinical and pathological entity first described in 1983.
  • Understanding its genesis, and macro- and microscopic features is crucial for diagnosis and treatment.

Observation:

  • Two cases of aggressive angiomyxoma are detailed, occurring in 32- and 38-year-old women.
  • Both tumors originated in the lesser pelvis.

Findings:

  • Complete surgical extirpation is the recommended treatment for aggressive angiomyxoma.
  • Despite radical surgery, frequent local relapses occur, often detected by imaging (ultrasonography and CT) before clinical manifestation.

Implications:

  • Aggressive angiomyxoma characteristically shows local recurrence without distant metastasis.

Related Experiment Videos

  • Close follow-up with imaging is essential for early detection of relapses post-surgery.